R3CR Blog
Phytocannabinoids: Regulators Turn to Science
As the FY2026 Agricultural Appropriations Act forces regulators to rely on molecular structures to define hemp, phytocannabinoid compliance is shifting. At R3CR, we translate these complex regulatory updates into validated policy guidance, helping scientists secure DEA registrations and protect the integrity of their clinical investigations.
Cannabis Rescheduling: Implications for Researchers
The federal government is moving to reschedule cannabis from Schedule I to Schedule III, a shift with profound implications for the scientific community. This change streamlines DEA registration and acquisition processes, significantly reducing barriers that have historically impeded clinical research. Explore the regulatory evolution and logistical impacts for licensed researchers.